Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients

NCT00504543 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
311
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals